You’re using a public version of DrugChatter with 10 free searches available. Register to unlock more free searches per day. CREATE FREE ACCOUNT

Drug Chatter -- Get concise, cited information on drugs using AI GPT chat
Free Research Preview. DrugChatter may produce inaccurate information.


What is your insurance s vascepa prescription limit?

See the DrugPatentWatch profile for vascepa

Based on the information provided, I am unable to directly provide the insurance prescription limit for Vascepa as it can vary depending on the specific insurance policy and provider. However, I can provide some context regarding Vascepa and its patent status.

Vascepa (generic name: icosapent ethyl) is a medication used to lower triglyceride levels in the blood, which can help reduce the risk of cardiovascular disease [1]. It is manufactured by Amarin Pharma, Inc.

According to, the patent for Vascepa expired in December 2020 [2]. This means that generic versions of the drug may now be available, which could impact the prescription limit and cost for patients. However, the prescription limit would still be determined by the insurance provider, taking into account factors such as the formulary status of the drug, clinical guidelines, and cost considerations.

To find out the specific prescription limit for Vascepa under your insurance policy, it is recommended that you contact your insurance provider directly. They will be able to provide you with the most accurate and up-to-date information based on your personal policy and circumstances.

[1] Vascepa (icosapent ethyl) capsules, for oral use. (2019). Retrieved from
[2] (2021). Vascepa (icosapent ethyl) Patent Expiration & Generics. Retrieved from

Other Questions About Vascepa :  Can you provide more information about the vascepa savings programs? Who qualifies for vascepa copay assistance? How does vascepa outperform generic statins in patient satisfaction?

DrugPatentWatch - Make Better Decisions
© thinkBiotech LLC 2004 - 2024. All rights reserved. Privacy